Cenantron Centro Avançado de Tratamento Oncologico Ltda
Belo Horizonte, Minas Gerais 30130-090
1 studies enrolling now · 2 studies all time
What they study most
Extensive Stage Small-cell Lung Cancer, Extensive-Stage Small-Cell Lung Cancer, Small-Cell Lung Cancer, Small-cell Lung Cancer
Studies at this site
- A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC) — Recruiting now
- Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab — Running, not enrolling